"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.
The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.
Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.
In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.
Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.
The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.
Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.
Denne historien er fra March 22, 2024-utgaven av Newsweek US.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra March 22, 2024-utgaven av Newsweek US.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Terry Crews
FOR TERRY CREWS, THERE ARE NO RULES.
Carrie Coon
CARRIE COON IS HAVING A MOMENT, EVEN THOUGH YOU MAY NOT RECognize her.
Still Doin' It Well
Ahead of the release of his new album, The FORCE, LL Cool J told Newsweek of his strong desire to keep contributing to the hip-hop culture he helped create
WORLD'S MOST TRUSTWORTHY COMPANIES 2024
TRUST IS AN ESSENTIAL PART OF ANY RELATIONSHIP-FROM PERsonal relationships to ties between businesses and consumers.
HOPE and HEALING on HORSEBACK
IT'S BEEN A DECADE SINCE ISIS COMMITTED GENOCIDE AGAINST IRAQ'S YAZIDI POPULATION. MORE THAN 100,000 YAZIDIS REMAIN DISPLACED BUT WORKERS AND ANIMALS AT AN EQUINE THERAPY CENTER ARE PROVIDING RELIEF
Is College Worth It?
AMERICANS are LOSING FAITH in HIGHER EDUCATION amid RISING TUITION FEES, UNCERTAIN PAYOFF and CULTURE WARS on CAMPUS
An integrated model for water management
Alkhorayef Water and Power Technologies has deep expertise and synergistic capabilities across the full water and wastewater value chain
Investments that are transforming life in Saudi Arabia
Abdullah Al Othaim Investment Company is creating distinctive destinations and experiences that encompass multiple sectors
A Kinder and Gentler Nick Cave
After a period of personal upheaval, the famed Bad Seeds singer returns with the vibrant and optimistic 'Wild God'
Fleeing War and Scams
Newsweek spoke to three Ukrainians who have been targeted by \"sponsors\" trying to profit from applicants seeking refuge in the U.S. via a humanitarian scheme
